ConceptioArchiveClinicalTrials.gov
ClinicalTrials.govpublic full text

An Open Label Study to Evaluate Safety, Tolerability and Clinical Utility of ULTRACET® (37.5mg Tramadol Hydrochloride/325mg Acetaminophen) for the Treatment of Breakthrough Pain in Cancer Patients

Johnson & Johnson Taiwan Ltd · 2005
ClinicalTrials.gov · Datasets · License: Public Domain · 2005
Open Source ↗
acetaminophencancer-painpain
pain, cancer pain, breakthrough pain, acetaminophen, tramadol hydrochloride, ultracet, interventional, phase4
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 877443
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.